Cognitive testing to evaluate revisions to the Vaccine Adverse Event Reporting System (VAERS) reporting form

Ítems similars

• Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003–2013
  per: Sukumaran, Lakshmi, et al.
  Publicat: (2015)
• Safety of bivalent human papillomavirus vaccine in the US vaccine adverse event reporting system (VAERS), 2009–2017
  per: Suragh, Tiffany A., et al.
  Publicat: (2018)
• Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)
  per: Shimabukuro, Tom T., et al.
  Publicat: (2015)
• Surveillance of Adverse Events After the First Trivalent Inactivated Influenza Vaccine Produced in Mammalian Cell Culture (Flucelvax®) Reported to the Vaccine Adverse Event Reporting System (VAERS), United States, 2013-2015
  per: Moro, Pedro L., et al.
  Publicat: (2015)
• Adverse events after Fluzone® Intradermal vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2011–2013()
  per: Moro, Pedro L., et al.
  Publicat: (2013)